Modulation of the immune system in the mouse 1. Drug administration prior to antien sensitization
- 1 September 1980
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 10 (4) , 378-388
- https://doi.org/10.1007/bf01971444
Abstract
A model has been developed in the mouse in which metylated bovine serum albumin (MBSA) and sheep red blood cells have been used to produced delayed type hypersensitivity (DTH) and humoral immunity (HI), respectively. The time coruse between antigen sensitization and challenge was chosen such that cyclophosphamide (CY), administered prior to sensitization, produced DTH enhancement and also produced suppression of HI when administered at high doses. A number of other drugs have been examined in this model but only CY-like drugs, viz. alkylating agents, produced similar DTH enhancement. DTH was suppressed in a few cases. The HI response was enhanced or suppressed by a number of unrelated drugs. CY was the only alkylatng agent to suppress the antibody titre. The mechanisms for these drug effects are uncertain. However, a number of drugs elicit effects on either DTH or HI which suggests there is selective removal of certain cell populations rather than non-specific cytotoxicity. Possible theories for the effects observed are discussed. These studies also suggest that CY possesses unique properties in this particular model.Keywords
This publication has 31 references indexed in Scilit:
- Regulation of delayed‐type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed‐type hypersensitivity to sheep erythrocytes in miceEuropean Journal of Immunology, 1978
- Enhancing effect of low dose cyclophosphamide treatment on the in vitro antibody responseEuropean Journal of Immunology, 1977
- Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in miceNature, 1976
- Selective Suppression of Humoral Immunity by Antineoplastic DrugsAnnual Review of Pharmacology and Toxicology, 1976
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.The Journal of Experimental Medicine, 1975
- B-cell suppression of delayed hypersensitivity reactionsNature, 1974
- POTENTIATION OF T-CELL-MEDIATED IMMUNITY BY SELECTIVE SUPPRESSION OF ANTIBODY FORMATION WITH CYCLOPHOSPHAMIDEThe Journal of Experimental Medicine, 1974
- Anti-inflammatory mechanism of inflamed-tissue factorInflammation Research, 1973
- Preferential development by mice of delayed hypersensitivity to purified basic proteinsJournal of Allergy, 1968